nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection
|
Fendt, Liane |
|
2010 |
128 |
2 |
p. 327-336 |
artikel |
2 |
Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms
|
Kravchenko, Julia |
|
2011 |
128 |
2 |
p. 483-493 |
artikel |
3 |
Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up
|
Lemieux, Julie |
|
2011 |
128 |
2 |
p. 563-566 |
artikel |
4 |
Breast cancer screening and ethnicity in the United States: implications for health disparities research
|
Miranda, Patricia Y. |
|
2011 |
128 |
2 |
p. 535-542 |
artikel |
5 |
Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival
|
Moran, Meena S. |
|
2011 |
128 |
2 |
p. 543-551 |
artikel |
6 |
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
|
Koch, Manuel |
|
2010 |
128 |
2 |
p. 337-346 |
artikel |
7 |
Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis
|
Zhang, Chun |
|
2011 |
128 |
2 |
p. 467-472 |
artikel |
8 |
Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer
|
Wu, Xinyu |
|
2010 |
128 |
2 |
p. 391-400 |
artikel |
9 |
Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial
|
Li, Xiao-Mei |
|
2011 |
128 |
2 |
p. 411-419 |
artikel |
10 |
Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence
|
Fu, Huazhou |
|
2011 |
128 |
2 |
p. 595-598 |
artikel |
11 |
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
|
Lalisang, R. I. |
|
2011 |
128 |
2 |
p. 437-445 |
artikel |
12 |
Erratum to: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
|
Farante, Gabriel |
|
2010 |
128 |
2 |
p. 379 |
artikel |
13 |
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
|
Razis, E. |
|
2011 |
128 |
2 |
p. 447-456 |
artikel |
14 |
Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population
|
Zhou, Ping |
|
2011 |
128 |
2 |
p. 527-534 |
artikel |
15 |
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry
|
Graña, B. |
|
2011 |
128 |
2 |
p. 573-579 |
artikel |
16 |
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
|
Ignatov, Atanas |
|
2011 |
128 |
2 |
p. 457-466 |
artikel |
17 |
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue
|
Lin, Suling J. |
|
2011 |
128 |
2 |
p. 505-516 |
artikel |
18 |
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands
|
Ruiterkamp, J. |
|
2011 |
128 |
2 |
p. 495-503 |
artikel |
19 |
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)
|
Oberguggenberger, Anne |
|
2011 |
128 |
2 |
p. 553-561 |
artikel |
20 |
Limited evidence supported the association of HRAS1 polymorphism with breast cancer risk
|
Zhang, Xiujun |
|
2011 |
128 |
2 |
p. 585-587 |
artikel |
21 |
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients
|
Vandorpe, T. |
|
2011 |
128 |
2 |
p. 429-435 |
artikel |
22 |
No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update
|
He, Taiping |
|
2011 |
128 |
2 |
p. 589-591 |
artikel |
23 |
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts
|
Nukatsuka, Mamoru |
|
2010 |
128 |
2 |
p. 381-390 |
artikel |
24 |
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control
|
Albert, Jeffrey M. |
|
2011 |
128 |
2 |
p. 421-427 |
artikel |
25 |
Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73
|
Wong, Su Wei |
|
2010 |
128 |
2 |
p. 301-313 |
artikel |
26 |
Reproductive factors associated with mammographic density: a Korean co-twin control study
|
Sung, Joohon |
|
2011 |
128 |
2 |
p. 567-572 |
artikel |
27 |
RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype
|
Habashy, Hany Onsy |
|
2010 |
128 |
2 |
p. 315-326 |
artikel |
28 |
Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study
|
Velentzis, Louiza S. |
|
2011 |
128 |
2 |
p. 473-482 |
artikel |
29 |
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands—associations with stage at diagnosis and survival
|
Aarts, M. J. |
|
2011 |
128 |
2 |
p. 517-525 |
artikel |
30 |
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer
|
Narod, Steven A. |
|
2011 |
128 |
2 |
p. 581-583 |
artikel |
31 |
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
|
Farante, Gabriel |
|
2010 |
128 |
2 |
p. 369-378 |
artikel |
32 |
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial
|
O’Malley, F. P. |
|
2011 |
128 |
2 |
p. 401-409 |
artikel |
33 |
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth
|
Tolhurst, Robert S. |
|
2010 |
128 |
2 |
p. 357-368 |
artikel |
34 |
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
|
Junttila, Teemu T. |
|
2010 |
128 |
2 |
p. 347-356 |
artikel |
35 |
Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk
|
Ding, Zhishan |
|
2011 |
128 |
2 |
p. 593-594 |
artikel |